Global Calcium Folinate 麻豆原创 Research Report 2024

Publication ID:

PB505248758

Publication Date:

May 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Calcium Folinate, also known as leucovorin calcium, is a drug similar to folic acid. Commonly used as an antidote to an overdose of antifolate metabolites, as well as Megaloblastic anemia and Leukopenia.
The global Calcium Folinate market was valued at US$ 97 million in 2023 and is anticipated to reach US$ 167.5 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
North American market for Calcium Folinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Calcium Folinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Calcium Folinate in Retail Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Calcium Folinate include Merck, Teva, Ingenus, Mylan, West-Ward Pharmaceuticals, Sagent Pharmaceuticals, Fresenius Kabi USA, Hubei Jusheng Technology and Major Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Calcium Folinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Folinate.
Report Scope
The Calcium Folinate market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcium Folinate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcium Folinate companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Merck
Teva
Ingenus
Mylan
West-Ward Pharmaceuticals
Sagent Pharmaceuticals
Fresenius Kabi USA
Hubei Jusheng Technology
Major Pharmaceuticals
American Health Packaging
BluePoint Laboratories
Segment by Type
Tablet
Injection
Capsule
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Calcium Folinate companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Calcium Folinate 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Injection
1.2.4 Capsule
1.3 麻豆原创 by Application
1.3.1 Global Calcium Folinate 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Calcium Folinate 麻豆原创 Perspective (2019-2030)
2.2 Calcium Folinate Growth Trends by Region
2.2.1 Global Calcium Folinate 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Calcium Folinate Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Calcium Folinate Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Calcium Folinate 麻豆原创 Dynamics
2.3.1 Calcium Folinate Industry Trends
2.3.2 Calcium Folinate 麻豆原创 Drivers
2.3.3 Calcium Folinate 麻豆原创 Challenges
2.3.4 Calcium Folinate 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Calcium Folinate Players by Revenue
3.1.1 Global Top Calcium Folinate Players by Revenue (2019-2024)
3.1.2 Global Calcium Folinate Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Calcium Folinate 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Calcium Folinate Revenue
3.4 Global Calcium Folinate 麻豆原创 Concentration Ratio
3.4.1 Global Calcium Folinate 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Calcium Folinate Revenue in 2023
3.5 Calcium Folinate Key Players Head office and Area Served
3.6 Key Players Calcium Folinate Product Solution and Service
3.7 Date of Enter into Calcium Folinate 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Calcium Folinate Breakdown Data by Type
4.1 Global Calcium Folinate Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Calcium Folinate Forecasted 麻豆原创 Size by Type (2025-2030)
5 Calcium Folinate Breakdown Data by Application
5.1 Global Calcium Folinate Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Calcium Folinate Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Calcium Folinate 麻豆原创 Size (2019-2030)
6.2 North America Calcium Folinate 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Calcium Folinate 麻豆原创 Size by Country (2019-2024)
6.4 North America Calcium Folinate 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Calcium Folinate 麻豆原创 Size (2019-2030)
7.2 Europe Calcium Folinate 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Calcium Folinate 麻豆原创 Size by Country (2019-2024)
7.4 Europe Calcium Folinate 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Calcium Folinate 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Calcium Folinate 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Calcium Folinate 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Calcium Folinate 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Calcium Folinate 麻豆原创 Size (2019-2030)
9.2 Latin America Calcium Folinate 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Calcium Folinate 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Calcium Folinate 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Calcium Folinate 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Calcium Folinate 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Calcium Folinate 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Calcium Folinate 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Calcium Folinate Introduction
11.1.4 Merck Revenue in Calcium Folinate Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Calcium Folinate Introduction
11.2.4 Teva Revenue in Calcium Folinate Business (2019-2024)
11.2.5 Teva Recent Development
11.3 Ingenus
11.3.1 Ingenus Company Detail
11.3.2 Ingenus Business Overview
11.3.3 Ingenus Calcium Folinate Introduction
11.3.4 Ingenus Revenue in Calcium Folinate Business (2019-2024)
11.3.5 Ingenus Recent Development
11.4 Mylan
11.4.1 Mylan Company Detail
11.4.2 Mylan Business Overview
11.4.3 Mylan Calcium Folinate Introduction
11.4.4 Mylan Revenue in Calcium Folinate Business (2019-2024)
11.4.5 Mylan Recent Development
11.5 West-Ward Pharmaceuticals
11.5.1 West-Ward Pharmaceuticals Company Detail
11.5.2 West-Ward Pharmaceuticals Business Overview
11.5.3 West-Ward Pharmaceuticals Calcium Folinate Introduction
11.5.4 West-Ward Pharmaceuticals Revenue in Calcium Folinate Business (2019-2024)
11.5.5 West-Ward Pharmaceuticals Recent Development
11.6 Sagent Pharmaceuticals
11.6.1 Sagent Pharmaceuticals Company Detail
11.6.2 Sagent Pharmaceuticals Business Overview
11.6.3 Sagent Pharmaceuticals Calcium Folinate Introduction
11.6.4 Sagent Pharmaceuticals Revenue in Calcium Folinate Business (2019-2024)
11.6.5 Sagent Pharmaceuticals Recent Development
11.7 Fresenius Kabi USA
11.7.1 Fresenius Kabi USA Company Detail
11.7.2 Fresenius Kabi USA Business Overview
11.7.3 Fresenius Kabi USA Calcium Folinate Introduction
11.7.4 Fresenius Kabi USA Revenue in Calcium Folinate Business (2019-2024)
11.7.5 Fresenius Kabi USA Recent Development
11.8 Hubei Jusheng Technology
11.8.1 Hubei Jusheng Technology Company Detail
11.8.2 Hubei Jusheng Technology Business Overview
11.8.3 Hubei Jusheng Technology Calcium Folinate Introduction
11.8.4 Hubei Jusheng Technology Revenue in Calcium Folinate Business (2019-2024)
11.8.5 Hubei Jusheng Technology Recent Development
11.9 Major Pharmaceuticals
11.9.1 Major Pharmaceuticals Company Detail
11.9.2 Major Pharmaceuticals Business Overview
11.9.3 Major Pharmaceuticals Calcium Folinate Introduction
11.9.4 Major Pharmaceuticals Revenue in Calcium Folinate Business (2019-2024)
11.9.5 Major Pharmaceuticals Recent Development
11.10 American Health Packaging
11.10.1 American Health Packaging Company Detail
11.10.2 American Health Packaging Business Overview
11.10.3 American Health Packaging Calcium Folinate Introduction
11.10.4 American Health Packaging Revenue in Calcium Folinate Business (2019-2024)
11.10.5 American Health Packaging Recent Development
11.11 BluePoint Laboratories
11.11.1 BluePoint Laboratories Company Detail
11.11.2 BluePoint Laboratories Business Overview
11.11.3 BluePoint Laboratories Calcium Folinate Introduction
11.11.4 BluePoint Laboratories Revenue in Calcium Folinate Business (2019-2024)
11.11.5 BluePoint Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Merck
Teva
Ingenus
Mylan
West-Ward Pharmaceuticals
Sagent Pharmaceuticals
Fresenius Kabi USA
Hubei Jusheng Technology
Major Pharmaceuticals
American Health Packaging
BluePoint Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.